Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for VTE Prophylaxis in Acutely Ill Medical Patients
NCT00457002Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 35
01
Overview
A Phase 3 trial of apixaban in venous thromboembolism (VTE), sponsored by Bristol Myers Squibb. Started Jun 2007; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00457002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457002.